Long-Lasting Control of Triple-Negative Metastatic Breast Cancer with the Novel Drug Combination Ixabepilone and Capecitabine - Case Report

作者：Vrdoljak Eduard^*; Mise Branka Petric; Lukic Blanka; Curic Zvonimir; Boskovic Lidija; Tica Ivana

来源：Onkologie, 2010, 33(1-2): 53-56.

DOI：10.1159/000264615

• Metastatic breast cancer
• Taxane
• Ixabepilone
• Peripheral neuropathy

Background: The optimal duration of ixabepilone and capecitabine chemotherapy combination is currently not known and will most likely be patient-specific based on efficacy, toxicity, quality of life, and patient preference. Case Report: We report an extremely long duration of chemotherapy with ixabepilone and capecitabine (42 cycles) in a patient with triple-negative metastatic breast cancer previously treated with anthracyclines and taxanes. Partial remission was achieved, and acceptable toxicity was observed. Conclusions: This report adds to the pool of knowledge regarding the use of this important new metastatic breast cancer regimen, especially with respect to the optimal duration of its use.

• 出版日期2010